Natural history of cervical squamous intraepithelial lesions: a meta-analysis*1
Abstract
Objective To define the strengths and weaknesses of existing research on the natural history of cervical squamous intraepithelial lesions (SIL) and to estimate rates of progression and regression without treatment. Data sources Studies of women whose cervical smears showed squamous atypia or worse and who were observed for a minimum of 6 months were identified by a search of MEDLINE from 1966 to 1996, Current Contents, the Federal Research in Progress database, and references of review articles and identified studies, and by experts in the field. Methods of study selection Fifteen of 81 studies were eligible for data extraction. To be eligible, studies had to report a minimum of 6 months' follow-up without treatment; relate entry cytologic findings to outcomes; and report entry cytologic findings so that the study population could be stratified into categories of atypical cells of undetermined significance (ASCUS), low-grade SIL, or high-grade SIL. Studies published before 1970 were excluded. Tabulation, integration, and results Eligible studies, representing 27,929 patients, were stratified according to entry cytologic findings. The following rates of progression to high-grade SIL at 24 months were found: ASCUS, 7.13% (95% confidence interval [CI] 0.8%, 13.5%); low-grade SIL, 20.81% (6.08%, 35.55%); and high-grade SIL, 23.37% (12.82%, 32.92%). The following rates of invasive cancer at 24 months were found: ASCUS, 0.25% (0%, 2.25%); low-grade SIL, 0.15% (0%, 0.71%); and high-…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The probability of progression from HPV infection to precancerous states or invasive cancer and regression to previous or normal stage was based on pooled estimates of 2 meta-analyses.
“Specifically, the probability of progression from HPV infection to precancerous states or invasive cancer and regression to previous or normal stage was based on the pooled estimates of 2 meta-analyses studies. [19, 31]”
From Cost effectiveness of strategies for cervical cancer prevention in India (2020) · cites this paper as [19]
Most of the probabilities of progression and regression for the natural history HPV based cancer cervix were based on the meta-analysis of international studies.
“Similarly, most of the probabilities of progression and regression for the natural history HPV based cancer cervix were based on the meta-analysis of international studies. [19, 31]”
From Cost effectiveness of strategies for cervical cancer prevention in India (2020) · cites this paper as [19]
Cites
Heterogeneity in Meta-analysis of Data from Epidemiologic Studies: A Commentary
Colditz, G. A., Burdick, E., & Mosteller, F. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117644 · Cited by 245 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406 · see citing works
Cost effectiveness of strategies for cervical cancer prevention in India
Chauhan, A. S., Prinja, S., Srinivasan, R., Rai, B., Malliga, J., Jyani, G., Gupta, N., & Ghoshal, S. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238291 · Cited by 75 · see citing works
“[19, 31] Another strength of our study was the use of local data on the cost of screening, treatment of cervical cancer and HRQoL valuation.”
BackgroundMethod
- Authors
- MELNIKOW, J.
- Affiliations
- University of California, Davis (US)
- Corresponding author
- MELNIKOW, J
- ORCID
- MELNIKOW, J
- Venue
- Obstetrics & Gynecology
- Published
- 1998-10
- Volume
- 92
- Issue
- 4
- Pages
- 727-735
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2053238499
- Cited by
- 435
- References
- 1
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 8 · 2020: 13 · 2019: 16 · 2018: 9 · 2017: 16 · 2016: 13 · 2015: 20 · 2014: 15 · 2013: 28 · 2012: 19
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca070104-02)
- National Cancer Institute (R01-CA70104-0)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- cervical squamous intraepithelial lesions, natural history (disease), disease progression, regression analysis, ASCUS, cervical cancer, cervical cytology, study heterogeneity, risk factors for progression, follow-up duration, follow-up bias, confounding, publication bias
- MeSH terms
- Carcinoma in Situ, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Female, Follow-Up Studies, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review